Inventor · disambiguated record
Bryan T. Oronsky
Also filed as: ORONSKY BRYAN · ORONSKY BRYAN T · ORONSKY BRYAN TODD
29 granted patents·45 pending applications·170 citations·filing 2005–2025
96Inventor score
Top patents by PatentIndex Score
74 records- 0197US9987270B1Treatment of gliomas using organonitro compound combination therapyEPICENTRX INC·Filed 2016·Granted Jun 5, 2018·16 cites·35 claims
- 0296US9468625B2Organonitro thioether compounds and medical uses thereofEPICENTRX INC·Filed 2015·Granted Oct 18, 2016·15 cites·20 claims
- 0394US11701351B2Treatment of gliomas using organonitro compound combination therapyEPICENTRX INC·Filed 2021·Granted Jul 18, 2023·2 cites·20 claims
- 0494US8664247B2Acyclic organonitro compounds for use in treating cancerSCICINSKI JAN·Filed 2012·Granted Mar 4, 2014·17 cites·13 claims
- 0593US11008287B2Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in medicineEPICENTRX INC·Filed 2017·Granted May 18, 2021·9 cites·19 claims
- 0692US10543208B2Treatment of gliomas using organonitro compound combination therapyEPICENTRX INC·Filed 2018·Granted Jan 28, 2020·12 cites·12 claims
- 0792US8138169B2Combination therapy for bipolar disorderORONSKY BRYAN T·Filed 2009·Granted Mar 20, 2012·26 cites·16 claims
- 0891US10342778B1Treatment of brain metastases using organonitro compound combination therapyEPICENTRX INC·Filed 2016·Granted Jul 9, 2019·13 cites·30 claims
- 0990US9139519B2Organonitro thioether compounds and medical uses thereofSCICINSKI JAN·Filed 2012·Granted Sep 22, 2015·18 cites·24 claims
- 1089US11576895B2Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanoneEPICENTRX INC·Filed 2017·Granted Feb 14, 2023·4 cites·19 claims
- 1188US12109348B2Medication infusion devices, systems, and methodsEPICENTRX INC·Filed 2020·Granted Oct 8, 2024·2 cites·23 claims
- 1288US11510901B2Methods and compositions utilizing RRx-001 combination therapy for radioprotectionEPICENTRX INC·Filed 2019·Granted Nov 29, 2022·7 cites·20 claims
- 1388US11160784B1Treatment of brain metastases using organonitro compound combination therapyEPICENTRX INC·Filed 2019·Granted Nov 2, 2021·8 cites·19 claims
- 1488US10906957B2Immunomodulatory fusion proteinsEPICENTRX INC·Filed 2017·Granted Feb 2, 2021·2 cites·8 claims
- 1587US11744859B2Compositions and methods for parenteral administration of therapeutic agentsEPICENTRX INC·Filed 2018·Granted Sep 5, 2023·2 cites·21 claims
- 1686US11660286B2Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood productsEPICENTRX INC·Filed 2019·Granted May 30, 2023·3 cites·6 claims
- 1786US11253608B2Recombinant adenoviruses carrying transgenesEPICENTRX INC·Filed 2018·Granted Feb 22, 2022·2 cites·24 claims
- 1884US12291726B2A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoterEPICENTRX INC·Filed 2024·Granted May 6, 2025·0 cites·19 claims
- 1984US2025074967A1Immunomodulatory fusion proteinsEPICENTRX INC·Filed 2024·Application pending·0 cites
- 2081US9511016B2Topical composition for treating painORONSKY BRYAN T·Filed 2007·Granted Dec 6, 2016·6 cites·24 claims
- 2181US8784872B2Formulation for decreasing tobacco, alcohol, drug or food consumptionORONSKY BRYAN T·Filed 2007·Granted Jul 22, 2014·3 cites·22 claims
- 2280US12357607B2Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanoneEPICENTRX INC·Filed 2022·Granted Jul 15, 2025·0 cites·37 claims
- 2379US11834492B2Human IL-10 receptor alpha fusion proteinsEPICENTRX INC·Filed 2018·Granted Dec 5, 2023·1 cites·11 claims
- 2477US12357608B2Methods and compositions utilizing RRx-001 combination therapy for radioprotectionEPICENTRX INC·Filed 2023·Granted Jul 15, 2025·0 cites·41 claims
- 2574US12048793B2Medication infusion devices, systems, and methodsEPICENTRX INC·Filed 2019·Granted Jul 30, 2024·2 cites·8 claims
- 2674US2024122977A1Compositions and methods for parenteral administration of therapeutic agentsEPICENTRX INC·Filed 2023·Application pending·0 cites
- 2773US12280123B2Recombinant adenoviruses carrying transgenesEPICENTRX INC·Filed 2022·Granted Apr 22, 2025·0 cites·17 claims
- 2873US2024374562A1Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood productsEPICENTRX INC·Filed 2023·Application pending·0 cites
- 2971US12054530B2Immunomodulatory fusion proteinsEPICENTRX INC·Filed 2021·Granted Aug 6, 2024·0 cites·14 claims
- 3071US2025099666A1Medication infusion devices, systems, and methodsEPICENTRX INC·Filed 2024·Application pending·0 cites
- 3171US2025161548A1Medication infusion devices, systems, and methodsEPICENTRX INC·Filed 2024·Application pending·0 cites
- 3267US2009131889A1Topical composition for treating painORONSKY BRYAN TODD·Filed 2008·Application pending·0 cites
- 3367US2009130182A1Topical compositions for treating painORONSKY BRYAN TODD·Filed 2008·Application pending·0 cites
- 3466US2009130048A1Topical Composition for Treating PainORONSKY BRYAN TODD·Filed 2007·Application pending·0 cites
- 3563US11999973B2Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoterEPICENTRX INC·Filed 2018·Granted Jun 4, 2024·0 cites·23 claims
- 3663US2025288555A1Systems and methods to improve exercise toleranceEPICENTRX INC·Filed 2023·Application pending·0 cites
- 3763US2025388930A1Tumor selective tata-box and caat-box mutantsEPICENTRX INC·Filed 2025·Application pending·0 cites
- 3862US2020375982A1Treatment of gliomas using organonitro compound combination therapyEPICENTRX INC·Filed 2019·Application pending·0 cites
- 3962US2010093673A1Pain relieving patchORONSKY BRYAN T·Filed 2009·Application pending·0 cites
- 4061US2025134858A1Compositions and methods for treatment of nafld and nash and related dyslipidemiasEPICENTRX INC·Filed 2023·Application pending·0 cites
- 4160US2008311218A1Topical composition for treating painORONSKY BRYAN T·Filed 2008·Application pending·0 cites
- 4260US2008311217A1Topicial composition for treating painORONSKY BRYAN T·Filed 2008·Application pending·0 cites
- 4360US2024293360A1Crystalline abdnaz compositions and methods of making and using the sameEPICENTRX INC·Filed 2022·Application pending·0 cites
- 4460US2008312583A1Topical composition for treating painORONSKY BRYAN T·Filed 2008·Application pending·0 cites
- 4559US2024382451A1Organonitro and sulfoxyalkyl organonitro compounds for use in treating medical disordersEPICENTRX INC·Filed 2022·Application pending·0 cites
- 4657US2009117059A1Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extracts thereof in combination with a steroidORONSKY BRYAN T·Filed 2008·Application pending·0 cites
- 4757US2010104614A1Providone compositions for wound healingORONSKY BRYAN T·Filed 2009·Application pending·0 cites
- 4857US2023235355A1Mono- and multi-valent sars-cov- 2 adenoviral vector vaccines and sars-cov-2 immune globulin and methods of useEPICENTRX INC·Filed 2021·Application pending·0 cites
- 4956US2009191283A1Treatment of headaches, neck pain, joint pain and inflammatory-type painORONSKY BRYAN TODD·Filed 2008·Application pending·0 cites
- 5055US2011250297A1Treatment of Hyperproliferative Disorders Using Cardiac GlycosidesORONSKY BRYAN T·Filed 2009·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bryan T. Oronsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →